Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839202 · ClinicalTrials.gov registry record · NA
Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00839202 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 7 participants.
The verdict
NCT00839202, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
A novel immuno-assay is being evaluated for the measurement of Factor VIII. Current procedure measures a rate assay which is subject to much artefact. The hypothesis is that the new assay will give a reading of absolute quantities of FVIII which will provide a more suitable indicator of FVIII content for clotting factor manufacturers, physicians and patients.
Interventions
- OTHER FVIII immuno-assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00839202
The ClinicalTrials.gov registry entry for NCT00839202 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FVIII immuno-assay is the first listed.
NCT00839202 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00839202 about?
NCT00839202 is a clinical study titled "Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay". A novel immuno-assay is being evaluated for the measurement of Factor VIII. Current procedure measures a rate assay which is subject to much artefact. The hypothesis is that the new assay will give a reading of absolute quantities of FVIII which will provide a more suitable indicator of FVIII conten...
What is the current status of trial NCT00839202?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2006-09. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00839202?
The interventions under investigation include: FVIII immuno-assay (OTHER).
Who is sponsoring clinical trial NCT00839202?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.